Catalysts for $SCNX
4 tracked
Apr 9, 2026
approval
REZENOPY (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→
Feb 18, 2026
approval
ARBLI (LOSARTAN POTASSIUM) — FDA approval
LOSARTAN POTASSIUM
→
Mar 13, 2025
approval
ARBLI (LOSARTAN POTASSIUM) — FDA approval
LOSARTAN POTASSIUM
→
Apr 19, 2024
approval
REZENOPY (NALOXONE HYDROCHLORIDE) — FDA approval
naloxone hydrochloride
→